5.4 C
New York
Friday, December 3, 2021
type here...
- Advertisement -spot_img

TAG

FDA

Business

CTI BioPharma [NASDAQ: CTIC] Reveals FDA Extends Review Period for Pacritinib

MZP Desk -
CTI BioPharma Corp. disclosed that FDA has informed the company about the decision it has made regarding the NDA for Pacritinib. The company...
Companies

QIAGEN [NYSE: QGEN] Announces FDA Approve LIAISON QuantiFERON-TB Gold Plus

MZP Desk -
QIAGEN N.V. disclosed that it has decided to widen access to latent TB testing in the U.S with its collaboration with DiaSorin. Both...
Business

ObsEva [NASDAQ: OBSV] Announces NDA for Linzagolix Receive FDA Approval

MZP Desk -
ObsEva SA disclosed that the New Drug Application (NDA) for Linzagolix for the management of heavy menstrual bleeding associated with uterine fibroids in...
Business

Epizyme [NASDAQ: EPZM] Get Fast Track Designation for EZM0414

MZP Desk -
Epizyme, Inc. disclosed that it has received the Fast-Track designation to EZM0414. EZM0414 is the Company’s novel, first-in-class, oral SETD2 inhibitor, as an...
Business

Why Ocugen [NASDAQ: OCGN] Stock Soaring Today?

MZP Desk -
Share of Ocugen, Inc. skyrocketed 5% during the trading session of Wednesday. The firm disclosed that it has filed an IND with the...
Business

Johnson & Johnson [NYSE: JNJ] Seeks FDA Approval for COVID-19 Booster Shot

MZP Desk -
Johnson & Johnson disclosed that it has decided to seek the authorization of the FDA for its COVID-19 booster shot in individuals 18...
Business

RedHill [NASDAQ: RDHL] Announces Trial for COVID-19 Therapy Unable to Meet Endpoint

MZP Desk -
RedHill Biopharma Ltd. disclosed introductory prime-line data from the 475-victim global Phase 2/3 study with opaganib in hospitalized victims with serious COVID-19 pneumonia....
Companies

Ocugen [NASDAQ: OCGN] Selects Manufacturing Partner for COVAXIN

MZP Desk -
Ocugen, Inc. has disclosed that it has chosen Jubilant HollisterStier of Spokane, Washington as its manufacturing partner for COVAXIN to make ready for...
Business

Pfizer’s [NYSE: PFE] PREVNAR Got Approval from US FDA

MZP Desk -
Pfizer Inc. disclosed that US FDA has provided the firm approval for PREVNAR 20 for the avoidance of persistent disease and pneumonia triggered...
Business

Reata [NASDAQ: RETA] is Soaring on Wednesday. Here’s Why

MZP Desk -
Shares of Reata Pharmaceuticals, Inc. has gained +17.94 at the time of writing on Wednesday. The strong performance of the firm came after...
123Page 1 of 3

Latest news

- Advertisement -spot_img

© MZP News. All rights reserved.

Navigation

Categories